RecruitingPhase IIEN originalLung cancerMetastatic / advanced

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

Researchers want to learn if using a study medicine called MK-1084 can help treat NSCLC. MK-1084 is a type of treatment called targeted therapy for the Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C gene change. The goal of this study is to learn about the safety of MK-1084 and to learn how many people have the cancer get smaller or go away during the study treatment.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Potwierdzony nowotwór płuc typu NSCLC, zaawansowany lub z przerzutami
  • Obecność mutacji KRAS G12C w tkance nowotworu lub we krwi
  • Możliwość pobrania próbki tkanki nowotworu do badania
  • Wyleczenie się z działań niepożądanych poprzednich terapii (stopień ≤1 lub powrót do stanu wyjściowego)
  • Jeśli zarażony HIV - virus kontrolowany lekami przeciwwirusowymi
  • Jeśli zarażony wirusem zapalenia wątroby B - bez wykrywanego wirusa, leczony co najmniej 4 tygodnie
  • Jeśli zarażony wirusem zapalenia wątroby C - bez wykrywanego wirusa

✗ Disqualifies

  • Diagnoza małokomórkowego raka płuca lub obecność małokomórkowych elementów w guzie
  • Zarażenie HIV z historią mięsaka Kaposiego lub choroby Castelmana
  • Aktywne zapalenie jelit wymagające leków immunosupresyjnych
  • Niekontrolowane poważne choroby serca lub naczyń mózgowych (niewydolność, arytmia, zawał w ostatnich 6 miesiącach)

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Last updated (source)
July 10, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (34)

Clermont Oncology Center ( Site 0041)

Clermont, United States

Sanford Health Roger Maris Cancer Center ( Site 0039)

Fargo, United States

Sanford Cancer Center Oncology Clinic ( Site 0038)

Sioux Falls, United States

Fundacion Arturo Lopez Perez ( Site 0167)

Santiago, Chile

Centro de Oncología de Precisión ( Site 0160)

Santiago, Chile

Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School ( Site 0318)

Nanjing, China

West China Hospital, Sichuan University ( Site 0315)

Chengdu, China

Kuopion Yliopistollinen Sairaala ( Site 0261)

Kuopio, Finland

Vaasan Keskussairaala ( Site 0263)

Vaasa, Finland

Turku University Hospital ( Site 0262)

Turku, Finland

HYKS Syöpätautien klinikka ( Site 0260)

Helsinki, Finland

Hong Kong Integrated Oncology Centre ( Site 0232)

Central, Hong Kong

Hong Kong United Oncology Centre ( Site 0231)

Kowloon, Hong Kong

Queen Mary Hospital ( Site 0230)

Pokfulam, Hong Kong

Fondazione IRCCS Istituto Nazionale Dei Tumori ( Site 0175)

Milan, Italy

Deventer Ziekenhuis ( Site 0272)

Deventer, Netherlands

Leids Universitair Medisch Centrum ( Site 0273)

Leiden, Netherlands

Severance Hospital Yonsei University Health System ( Site 0080)

Seoul, South Korea

Hospital Universitario Virgen de la Macarena ( Site 0093)

Seville, Spain

Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 0351)

Bangkok, Thailand

Erciyes University ( Site 0145)

Talas, Turkey (Türkiye)

Baskent University Dr. Turgut Noyan Research and Training Center ( Site 0141)

Adana, Turkey (Türkiye)

Koç Üniversitesi Hastanesi ( Site 0142)

Adana, Turkey (Türkiye)

Liv Hospital Ankara ( Site 0146)

Ankara, Turkey (Türkiye)

Hacettepe Universite Hastaneleri ( Site 0140)

Ankara, Turkey (Türkiye)

COMMUNAL NONPROFIT ENTERPRISE CLINICAL CENTER OF ONCOLOGY, HEMATOLOGY, TRANSPLANTOLOGY AND PALLIATI ( Site 0139)

Cherkasy, Ukraine

Medical Center "Mriya Med-Service"-Clinical Research Department ( Site 0465)

Kryvyi Rih, Ukraine

Communal Non-Commercial Enterprise "Prykarpatski Clinical On-Surgery department #2 ( Site 0132)

Ivano-Frankivsk, Ukraine

Limited Liability Company Ukrainian Center of Tomotherapy-Department of Chemotherapy ( Site 0467)

Kropyvnytskyi, Ukraine

Lviv Territorial Medical Union Multidisciplinary Clinical Hospital ( Site 0133)

Lviv, Ukraine

Communal Noncommercial Enterprise "Podillia Regional Oncolog-Cardiothoracic department ( Site 0131)

Vinnitsya, Ukraine

Uzhhorod Municipal Multidisciplinary Clinical Hospital of Uzhhorod City Council ( Site 0137)

Uzhhorod, Ukraine

VISION PARTNER Medical Centre ( Site 0135)

Kyiv, Ukraine

LIMITED LIABILITY COMPANY "MEDICAL CENTER "DOBROBUT-CLINIC" ( Site 0138)

Kyiv, Ukraine

Trial contact

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/11/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.